Asahi Kasei Pharma Applies for Approval of Famvir for Additional Indication - MarketWatch (press release)
Asahi Kasei Pharma Applies for Approval of Famvir for Additional IndicationMarketWatch (press release)The company obtained marketing approval for Famvir (generic name:famciclovir) in Japan, where it has been distributed under license by Maruho for the indication of herpes zoster (shingles) since July 2008.
Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade ... - Sacramento Bee
Medivir's Partner GSK Initiates OTC Launch of Xerclear® in Europe Under Trade .
Research and Markets: Dermatology Therapeutics Market to 2017 - Alopecia ... - Business Wire (press release)
Research and Markets: Dermatology Therapeutics Market to 2017 - Alopecia .
HERPES ZOSTER O FUOCO DI SANT'ANTONIO: I RIMEDI PER SCONFIGGERLO - Infosalute
HERPES ZOSTER O FUOCO DI SANT'ANTONIO: I RIMEDI PER SCONFIGGERLOInfosaluteLa terapia consigliata è quella farmacologica che si avvale di pomate antivirali a base famciclovir, aciclovir e il suo derivato valaciclovir, iniezioni intravenose di foscarnet, un farmaco che blocca l'attività enzimatica dell'herpes zoster e gli .